These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 8737145)
1. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. Teng R; Liston TE; Harris SC J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145 [TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Teng R; Harris SC; Nix DE; Schentag JJ; Foulds G; Liston TE J Antimicrob Chemother; 1995 Aug; 36(2):385-94. PubMed ID: 8522468 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and metabolism of single oral doses of trovafloxacin. Vincent J; Teng R; Dalvie DK; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250 [TBL] [Abstract][Full Text] [Related]
4. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers. Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin. Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074 [TBL] [Abstract][Full Text] [Related]
6. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans. Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287 [TBL] [Abstract][Full Text] [Related]
7. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin. Purkins L; Oliver SD; Willavize SA Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):431-3. PubMed ID: 9758288 [TBL] [Abstract][Full Text] [Related]
8. Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers. Chien SC; Wong FA; Fowler CL; Callery-D'Amico SV; Williams RR; Nayak R; Chow AT Antimicrob Agents Chemother; 1998 Apr; 42(4):885-8. PubMed ID: 9559801 [TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers. Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286 [TBL] [Abstract][Full Text] [Related]
10. Effect of trovafloxacin, a new fluoroquinolone antibiotic, on the steady-state pharmacokinetics of theophylline in healthy volunteers. Vincent J; Teng R; Dogolo LC; Willavize SA; Friedman HL J Antimicrob Chemother; 1997 Jun; 39 Suppl B():81-6. PubMed ID: 9222075 [TBL] [Abstract][Full Text] [Related]
11. Oral bioavailability of trovafloxacin with and without food in healthy volunteers. Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076 [TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of intravenous-to-oral treatment and single-dose intravenous or oral prophylaxis with trovafloxacin. Williams DJ; Hopkins S Am J Surg; 1998 Dec; 176(6A Suppl):74S-79S. PubMed ID: 9935261 [TBL] [Abstract][Full Text] [Related]
13. Phase I pilot study of the effects of trovafloxacin (CP-99,219) on the pharmacokinetics of theophylline in healthy men. Dickens GR; Wermeling D; Vincent J J Clin Pharmacol; 1997 Mar; 37(3):248-52. PubMed ID: 9089427 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin (CP 99,219), in infants and children following administration of a single intravenous dose of alatrofloxacin. Bradley JS; Kearns GL; Reed MD; Capparelli EV; Vincent J Antimicrob Agents Chemother; 2000 May; 44(5):1195-9. PubMed ID: 10770751 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers. Allen A; Bygate E; Oliver S; Johnson M; Ward C; Cheon AJ; Choo YS; Kim IC Antimicrob Agents Chemother; 2000 Jun; 44(6):1604-8. PubMed ID: 10817716 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys. Teng R; Girard D; Gootz TD; Foulds G; Liston TE Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571 [TBL] [Abstract][Full Text] [Related]
17. The bioavailability of nasogastric versus tablet-form oral trovafloxacin in healthy subjects. Vincent J; Teng R; Pelletier SM; Willavize SA; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):23S-26S. PubMed ID: 9935253 [TBL] [Abstract][Full Text] [Related]
18. Penetration of trovafloxacin into gynecologic tissues. Martens MG; Maccato M; Van Hook C; Vincent J Am J Surg; 1998 Dec; 176(6A Suppl):18S-22S. PubMed ID: 9935252 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219). Wise R; Mortiboy D; Child J; Andrews JM Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877 [TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetic effects of coadministration of morphine and trovafloxacin in healthy subjects. Vincent J; Hunt T; Teng R; Robarge L; Willavize SA; Friedman HL Am J Surg; 1998 Dec; 176(6A Suppl):32S-38S. PubMed ID: 9935255 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]